Bacteria: atypical and cell-wall-deficient

Chlamydia pneumoniae

Chlamydophila pneumoniae

General medical information for education only, not medical advice. Treatment considerations summarize published guidance at drug-class level; therapy is chosen by the treating clinician using susceptibility results, local resistance patterns and current guidelines.

Overview

An obligate intracellular bacterium spread by respiratory droplets.

Infections

Pharyngitis, sinusitis, bronchitis and atypical pneumonia.

Signs and symptoms

Sore throat and hoarseness followed by a prolonged cough; often mild.

Antibiotic and antimicrobial resistance

Clinically significant resistance to macrolides, tetracyclines or fluoroquinolones is not a recognized routine problem. Beta-lactams are ineffective against this intracellular organism.

Treatment considerations

Doxycycline, a macrolide or a respiratory fluoroquinolone.

Obligate intracellular bacteria (inclusions inside a host cell), schematic
Obligate intracellular bacteria (inclusions inside a host cell). Schematic, not to scale; InnovexLab.

Sources

  1. CDC. Chlamydia pneumoniae infection.
  2. ATS / IDSA. Community-Acquired Pneumonia in Adults guideline.

Sources accessed November 2026. Links open external sites that InnovexLab does not control.

Medical disclaimer

This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.

Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.

Sources, image credits and editorial policy

Discuss a testing program with InnovexLab

Review the panel that fits your patients, its specimen requirements, and how results and billing work.